4 results
Approved WMOCompleted
The objective of this study is to evaluate the safety of the PlenSat Digestible Balloons.
Approved WMORecruiting
To assess if venetoclax combined with FLA+GO (fludarabine, high-dose cytarabine, and gemtuzumab ozogamicin) will improve overall survival of children with relapsed acute myeloid leukemia (AML) compared to FLA+GO .
Approved WMORecruiting
The objective of this study is to evaluate the safety of the PlenSat Digestible Balloons.
Approved WMOPending
Primary objective:To assess, in an international pediatric study, the efficacy, in terms of event-free survival, of a combination of ATO and ATRA in newly diagnosed SR APL children and adolescents and to explore the safety and efficacy of a…